Tech Company Financing Transactions

Leash Biosciences Funding Round

Leash Biosciences, based in Salt Lake City, secured $9.3 million in funding from SpringTide Ventures, private investors and Metaplanet.

Transaction Overview

Company Name
Announced On
4/8/2024
Transaction Type
Venture Equity
Amount
$9,300,000
Round
Seed
Proceeds Purpose
The company intends to use the funds to support development of a foundational machine learning model of medicinal chemistry that can predict small molecule drug candidates for any protein.

Company Information

Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
48 S Rio Grande Street
Salt Lake City, UT 84101
USA
Phone
Undisclosed
Email Address
Overview
We're transforming drug design with a rich dataset built by screening millions of compounds against thousands of proteins to generate billions of data points, ideal for training advanced machine learning models. Finding better drugs faster by focusing on what matters: Data. All major machine learning problems have been solved by new data, not new algorithms. The data to solve drug discovery doesn't exist yet.
Profile
Leash Biosciences LinkedIn Company Profile
Social Media
Leash Biosciences Company Twitter Account
Company News
Leash Biosciences News
Facebook
Leash Biosciences on Facebook
YouTube
Leash Biosciences on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Ian Quigley
  Ian Quigley LinkedIn Profile  Ian Quigley Twitter Account  Ian Quigley News  Ian Quigley on Facebook
Chief Operating Officer
Ben Miller
  Ben Miller LinkedIn Profile  Ben Miller Twitter Account  Ben Miller News  Ben Miller on Facebook
Chief Technical Officer
Andrew Blevins
  Andrew Blevins LinkedIn Profile  Andrew Blevins Twitter Account  Andrew Blevins News  Andrew Blevins on Facebook
VP - Bus. Development
Becca Levin
  Becca Levin LinkedIn Profile  Becca Levin Twitter Account  Becca Levin News  Becca Levin on Facebook


 

 

Browse more venture capital transactions:

Prev: 4/8/2024: Honey Insurance venture capital transaction
Next: 4/8/2024: Pierrepont Therapeutics venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary